Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06509230

Prediction of Significant Liver Fibrosis

Multimodal Digital Image Fusion Technology Based on Deep Learning to Predict Significant Liver Fibrosis and Its Application in Multi-center Research

Status
Recruiting
Phase
Study type
Observational
Enrollment
700 (estimated)
Sponsor
Huang Haijun · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The deep learning method based on convolutional neural network (CNN) was used to extract the relevant features of liver fibrosis classification from the multi-modal information of digital pathological sections, clinical parameters and biomarkers of a large number of existing cases of liver puncture, and the U-Net architecture of CNN was used to segment and extract the features of clinical medical images.

Detailed description

Patients with chronic hepatitis B underwent B-ultrasound-guided liver biopsy, and were divided into mild liver fibrosis group (fibrosis grade 0-1, S1), significant liver fibrosis group (fibrosis grade 2, S2), advanced liver fibrosis group and early cirrhosis group (fibrosis grade 3-4, S3-4) according to the pathological results.In this study, 200 patients with different degrees of liver fibrosis and 200 normal volunteers were collected from 2018 to 2022, and their clinical biochemical data, imaging data and peripheral blood samples were collected.The pathological microenvironment characteristics, imaging characteristics, clinical parameter characteristics and other data of patients were extracted, and the distillation learning method based on teacher-student model was adopted to develop and construct a multi-modal big data analysis model for accurate grading of liver fibrosis, so as to achieve a non-invasive intelligent grading diagnosis system for liver fibrosis.

Conditions

Interventions

TypeNameDescription
OTHERThe fibrosis grades were grouped without drug intervention

Timeline

Start date
2024-07-20
Primary completion
2024-12-31
Completion
2026-12-31
First posted
2024-07-19
Last updated
2024-07-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06509230. Inclusion in this directory is not an endorsement.